Literature DB >> 31124729

A nomogram for predicting depression in patients with hepatocellular carcinoma: an observational cross-sectional study.

Yong Jia1, Wenlei Zhang2, Simiao You3, Min Li2, Lin Lei4, Li Chen1,5.   

Abstract

Objectives: Depression is common in hepatocellular carcinoma patients. Predicting depression is critical for managing hepatocellular carcinoma patients. The aim of this study was to establish a comprehensive visual predictive nomogram for calculating a probabilistic estimate of depression in hepatocellular carcinoma patients.
Methods: Two-hundred and sixty-nine patients diagnosed with hepatocellular carcinoma were included. The demographic and clinical information was collected from medical records. A nomogram was constructed based on the results of a multivariate regression analysis. Discrimination and calibration were used to assess its performance. A decision curve analysis was used to assess its clinical utility.
Results: One hundred and thirty-four (49.82%) hepatocellular carcinoma patients with depression were identified. The education level, social support, pain intensity, disclosure of the cancer diagnosis to the patient and Child-Pugh class were included in the nomogram. The AUC was 0.828, indicating good discrimination. The nomogram demonstrated calibration curves with slight deviation from the ideal predictions and a high net benefit in the decision curve analysis.Conclusions: We proposed a nomogram for the individualised prediction of depression in hepatocellular carcinoma patients with satisfactory performance and clinical utility.Key points/highlightsA visual, comprehensive and convenient nomogram was established for the prediction of depression in patients with hepatocellular carcinoma.The proposed nomogram showed satisfactory validity, discrimination and clinical utility, indicating good performance for predicting depression.The variables found to be sufficiently informative and predictive to warrant inclusion in the nomogram were the patient education level, pain intensity, social support, disclosure of the hepatocellular carcinoma diagnosis to the patient and Child-Pugh class.

Entities:  

Keywords:  Hepatocellular carcinoma; cancer; cross-sectional study; depression; nomogram

Mesh:

Year:  2019        PMID: 31124729     DOI: 10.1080/13651501.2019.1619777

Source DB:  PubMed          Journal:  Int J Psychiatry Clin Pract        ISSN: 1365-1501            Impact factor:   1.812


  6 in total

Review 1.  Psychological Burden and Psycho-Oncological Interventions for Patients With Hepatobiliary Cancers-A Systematic Review.

Authors:  Johanna Graf; Andreas Stengel
Journal:  Front Psychol       Date:  2021-05-05

2.  Role of lncRNA NR2F1-AS1 and lncRNA H19 Genes in Hepatocellular Carcinoma and Their Effects on Biological Function of Huh-7.

Authors:  Wen-Chao Ji; Guang-Jian Bao; Fang-Wu Yang; Lei Sun; Rui Han
Journal:  Cancer Manag Res       Date:  2021-02-03       Impact factor: 3.989

3.  A Prediction Model for Cognitive Impairment Risk in Colorectal Cancer after Chemotherapy Treatment.

Authors:  Shu-Ping Zhou; Su-Ding Fei; Hui-Hui Han; Jing-Jing Li; Shuang Yang; Chun-Yang Zhao
Journal:  Biomed Res Int       Date:  2021-02-20       Impact factor: 3.411

4.  Assessing the depression risk in the U.S. adults using nomogram.

Authors:  Yafeng Zhang; Wei Tian; Xinhao Han; Guangcan Yan; Yuanshuo Ma; Shan Huo; Yu Shi; Shanshan Dai; Xin Ni; Zhe Li; Lihua Fan; Qiuju Zhang
Journal:  BMC Public Health       Date:  2022-03-02       Impact factor: 3.295

5.  Development of a nomogram prediction model for depression in patients with systemic lupus erythematosus.

Authors:  Haoyang Chen; Hengmei Cui; Yaqin Geng; Tiantian Jin; Songsong Shi; Yunyun Li; Xin Chen; Biyu Shen
Journal:  Front Psychol       Date:  2022-09-14

6.  Constructing a Predictive Model of Depression in Chemotherapy Patients with Non-Hodgkin's Lymphoma to Improve Medical Staffs' Psychiatric Care.

Authors:  Cheng Hu; Qian Li; Ji Shou; Feng-Xian Zhang; Xia Li; Min Wu; Meng-Jing Xu; Li Xu
Journal:  Biomed Res Int       Date:  2021-07-17       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.